TELO
Telomir Pharmaceuticals, Inc.
1.20$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -11.4% | +9,696.4% | -72.3% | +454.5% | |
| – | – | +30,571.2% | +204.2% | +454.5% | |
| – | – | -13.2% | +102,753.9% | +475.5% | |
| – | – | -13.2% | +102,753.9% | +475.5% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | +613.8% | +35.5% | -49.0% | +109.7% | |
| – | +613.8% | +35.5% | -49.0% | +109.7% | |
| – | +387.3% | -82.6% | -7.5% | +407.1% | |
| – | +2,057.6% | +75.0% | -16.9% | -8.6% | |
| – | – | – | -81.3% | +819.6% | |
| – | – | – | – | – | |
| – | +0.0% | +0.0% | -0.2% | +7.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.